Bench International

Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs

Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs

Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs

Posted by Tom Murphy: The team at Bench International greatly appreciates the opportunity to work closely with Cardiff Oncology CEO Dr. Mark Erlander and his team in the recruitment of these two outstanding additions to their executive leadership team. Congratulations to CSO Dr. Tod Smeal and SVP of Regulatory Affairs Chuck Monahan. It’s been an honor and pleasure working with you.

Read the Cardiff Oncology press release: https://bit.ly/3ql8HZb